TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
Clinical trial NCT07100405 · RECRUITING
Trial details
- NCT number
- NCT07100405
- Sponsor
- Fudan University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-15
- Primary completion
- 2027-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.